The Russian developers of a coronavirus vaccine have developed immunity to the infection after self-administering it, Interfax reported Friday.
Scientists at the Gamaleya Research Center for Epidemiology and Microbiology “aren’t so much testing as protecting themselves to continue working,” its head Alexander Gintsburg told the news agency.
“Everyone’s alive, healthy and happy,” Gintsburg said when asked if the vaccine developers experienced any side effects. “As such, everyone involved in development is protected.”
Gintsburg did not say how many people took the vaccine, which uses a weakened virus to deliver small parts of a pathogen and stimulate an immune response. He identified the test subjects only as a “wide range” of developers, preclinical researchers and technologists.
The research center is awaiting the results of monkey trials in order to seek permission from the Health Ministry to begin clinical trials on humans, Gintsburg said.
Russia’s health minister said last week that a Covid-19 vaccine would be available as soon as late July. U.S. officials hope to develop one by the first half of 2021.
Russia is currently developing 47 coronavirus vaccines. World Health Organization data estimates that more than 100 draft vaccines were in development worldwide as of late April.
With 326,448 reported infections, Russia has the world’s second-highest number of coronavirus cases behind the United States.
A Message from The Moscow Times:
Dear readers,
We are facing unprecedented challenges. Russia's Prosecutor General's Office has designated The Moscow Times as an "undesirable" organization, criminalizing our work and putting our staff at risk of prosecution. This follows our earlier unjust labeling as a "foreign agent."
These actions are direct attempts to silence independent journalism in Russia. The authorities claim our work "discredits the decisions of the Russian leadership." We see things differently: we strive to provide accurate, unbiased reporting on Russia.
We, the journalists of The Moscow Times, refuse to be silenced. But to continue our work, we need your help.
Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just $2. It's quick to set up, and every contribution makes a significant impact.
By supporting The Moscow Times, you're defending open, independent journalism in the face of repression. Thank you for standing with us.
Remind me later.
